• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Helix Biomedix to Present at the PCITX Product Development Conference 2006

Posted on: Wednesday, 6 September 2006, 09:01 CDT

BOTHELL, Wash., Sept. 6 /PRNewswire-FirstCall/ -- Helix BioMedix, Inc. (BULLETIN BOARD: HXBM) today announced that Timothy Falla, Ph.D, Chief Scientific Officer, will present "Innate Immunity: A Rich Source of Bioactivity" at the PCITX Product Development Conference 2006. The conference is part of the HBA Health & Beauty America Exposition and Educational Conference to be held at the Jacob K. Javits Convention Center in New York City on September 12th through the 14th. Dr. Falla's presentation, which will take place on the 12th at 2:15pm, will be part of a product development panel discussion focusing on "New Developments in High Performance Ingredients."

The innate structure of the immune system of mammals, which is comprised in part of small bioactive peptides, allows for the protection of exposed and epithelial surfaces from infection as well as the stimulation of the necessary recovery processes after injury. Dr. Falla will discuss how such functions are largely mediated by peptides, whose bioactivities can be isolated and tailored for use in a wide range of consumer healthcare products. Helix BioMedix, Inc. has a number of preclinical stage peptide therapeutics that exploit a range of innate immunity functions including antimicrobial, anti-inflammatory and stimulatory activities.

The Personal Care Ingredients & Technology Expo (PCITX) focuses on recent advances and latest developments in ingredient technologies and bioengineering, as well as transfer and delivery systems for creating a new generation of cosmetics, skin care, hair care, and cosmeceutical products. The expo is part of the HBA Health & Beauty America Exposition and Educational Conference, which is considered the most important product development event and educational conference in North America for the beauty, health and wellness industries. Showcasing everything from formula to finish, HBA attracts more than 18,000 beauty and personal care professionals from all over the world. Information about the conferences can be found at http://www.personalcareexpo.com/ and http://www.hbaexpo.com/.

About Helix BioMedix

Helix BioMedix, Inc. is an early-stage biotechnology company that has a portfolio of issued patents that covers six distinct classes of peptides, covering over 1 million unique peptide sequences. The company's mission is to become the industry leader in developing and commercializing small proteins known as bioactive peptides. The antimicrobial and wound healing properties of these peptides qualify them for inclusion in a wide range of both pharmaceutical and consumer products. The company is currently focused on the development of selected peptides as topical anti-infectives and in wound healing. Non-pharmaceutical applications being pursued by Helix BioMedix include adjuvants for cosmetics/cosmeceuticals, personal care, plant health, animal health and wide-spectrum biocides. More information about the company and its proprietary peptides can be found on the company's website at http://www.helixbiomedix.com/.

Contact: Investor Relations: Cameron Associates Alison Ziegler, 212-554-5469 alison@cameronassoc.com

Helix BioMedix, Inc.

CONTACT: Alison Ziegler of Cameron Associates, +1-212-554-5469, oralison@cameronassoc.com, for Helix BioMedix, Inc.

Web site: http://www.helixbiomedix.com/http://www.hbaexpo.com/http://www.personalcareexpo.com/

Source: PRNewswire-FirstCall

More News in this Category